These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30666414)

  • 21. The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.
    Vanderschueren S; van der Veen A
    Clin Exp Rheumatol; 2017; 35(1):69-73. PubMed ID: 27606610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canakinumab in Schnitzler syndrome.
    Vanderschueren S; Knockaert D
    Semin Arthritis Rheum; 2013 Feb; 42(4):413-6. PubMed ID: 22901459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Schnitzler syndrome is a diagnostic challenge].
    Duhn PH; Thomsen SF; Nordin H
    Ugeskr Laeger; 2015 Jul; 177(30):. PubMed ID: 26240044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.
    de Koning HD; Bodar EJ; van der Meer JW; Simon A;
    Semin Arthritis Rheum; 2007 Dec; 37(3):137-48. PubMed ID: 17586002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].
    Adam Z; Krejcí M; Pour L; Hájek R
    Vnitr Lek; 2009 Dec; 55(12):1196-7. PubMed ID: 20070037
    [No Abstract]   [Full Text] [Related]  

  • 26. Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology.
    Soudet S; Fajgenbaum D; Delattre C; Forestier A; Hachulla E; Hatron PY; Launay D; Terriou L
    Curr Res Transl Med; 2018 Sep; 66(3):83-86. PubMed ID: 30108026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature.
    Tinazzi E; Puccetti A; Patuzzo G; Sorleto M; Barbieri A; Lunardi C
    Autoimmun Rev; 2011 May; 10(7):404-9. PubMed ID: 21256251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anakinra: an effective treatment in the Schnitzler syndrome.
    Vandenhende MA; Bentaberry F; Morlat P; Bonnet F
    Joint Bone Spine; 2011 Dec; 78(6):636-7. PubMed ID: 21550281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression.
    Masson Regnault M; Frouin E; Jéru I; Delwail A; Charreau S; Barbarot S; Néel A; Masseau A; Puéchal X; Kyndt X; Gayet S; Lifermann F; Asli B; Balguerie X; Blanchard-Delaunay C; Aubin F; Rizzi R; Rongioletti F; Boyé T; Gusdorf L; Bessis D; Morel F; Hainaut E; Lipsker D; Lecron JC
    Front Immunol; 2020; 11():588322. PubMed ID: 33324407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A woman with recurrent urticaria, joint pain and fever].
    Gran JT; Midtvedt Ø; Haug S
    Tidsskr Nor Laegeforen; 2011 Jan; 131(2):135-6. PubMed ID: 21267032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study.
    Krause K; Tsianakas A; Wagner N; Fischer J; Weller K; Metz M; Church MK; Maurer M
    J Allergy Clin Immunol; 2017 Apr; 139(4):1311-1320. PubMed ID: 27658762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schnitzler syndrome: treatment failure to rituximab but response to anakinra.
    Eiling E; Möller M; Kreiselmaier I; Brasch J; Schwarz T
    J Am Acad Dermatol; 2007 Aug; 57(2):361-4. PubMed ID: 17467852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schnitzler Syndrome Without a Monoclonal Gammopathy: A Case Report.
    Urbanski M; Holfeld K; Milne A; Abbas M
    J Cutan Med Surg; 2016 Nov; 20(6):575-578. PubMed ID: 27358310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.
    Huang Y; Wang Y; Yu F; Mao X; Wang B; Li J; Li L
    Front Immunol; 2022; 13():894464. PubMed ID: 35514998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review.
    Betrains A; Staels F; Vanderschueren S
    Semin Arthritis Rheum; 2020 Aug; 50(4):636-642. PubMed ID: 32502728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schnitzler Syndrome: a Review.
    Gusdorf L; Lipsker D
    Curr Rheumatol Rep; 2017 Aug; 19(8):46. PubMed ID: 28718061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra.
    Ahn MJ; Yu JE; Jeong J; Sim DW; Koh YI
    Yonsei Med J; 2018 Jan; 59(1):154-157. PubMed ID: 29214791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anakinra treatment in Schnitzler syndrome -  results of the first retrospective multicenter study in six patients from the Czech Republic].
    Szturz P; Sedivá A; Zurek M; Adam Z; Stork J; Cermáková Z; Steyerová P; Vokáčová A; Hrbek J; Sýkora M; Spička I; Mechl Z; Mayer J
    Klin Onkol; 2014; 27(2):111-26. PubMed ID: 24739048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Membranoproliferative glomerulonephritis with relapsing episodes of acute kidney injury in the Schnitzler syndrome].
    Rossi L; Casucci F; Teutonico A; Libutti P; Lisi P; Lomonte C; Basile C; Manna R
    G Ital Nefrol; 2019 Jun; 36(3):. PubMed ID: 31251000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CCL2 with systemic inflammation in Schnitzler syndrome.
    Krause K; Sabat R; Witte-Händel E; Schulze A; Puhl V; Maurer M; Wolk K
    Br J Dermatol; 2019 Apr; 180(4):859-868. PubMed ID: 30339714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.